{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:24:33Z","timestamp":1792549473396,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2019-I2M-5-058"],"award-info":[{"award-number":["2019-I2M-5-058"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["IDF152090-152"],"award-info":[{"award-number":["IDF152090-152"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010108","name":"Zhongshan Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403406"],"award-info":[{"award-number":["82403406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403555"],"award-info":[{"award-number":["82403555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403408"],"award-info":[{"award-number":["82403408"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003084"],"award-info":[{"award-number":["82003084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273386"],"award-info":[{"award-number":["82273386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273387"],"award-info":[{"award-number":["82273387"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.canlet.2025.218066","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:22:42Z","timestamp":1759209762000},"page":"218066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["STAT3 induced BRD9 activation promotes intrahepatic cholangiocarcinoma progression by enhancing CD36 controlled fatty acid metabolism"],"prefix":"10.1016","volume":"634","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1283-3547","authenticated-orcid":false,"given":"Yichao","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiutao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiren","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0256-4494","authenticated-orcid":false,"given":"Zheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9935","key":"10.1016\/j.canlet.2025.218066_bib1","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.canlet.2025.218066_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.32074\/1591-951X-252","article-title":"Cholangiocarcinoma","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"issue":"6","key":"10.1016\/j.canlet.2025.218066_bib3","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.suc.2024.04.003","article-title":"Cholangiocarcinoma","volume":"104","author":"Harrison","year":"2024","journal-title":"Surg. Clin. North Am"},{"issue":"4","key":"10.1016\/j.canlet.2025.218066_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.soc.2019.06.002","article-title":"Intrahepatic cholangiocarcinoma","volume":"28","author":"El-Diwany","year":"2019","journal-title":"Surg. Oncol. Clin."},{"issue":"2","key":"10.1016\/j.canlet.2025.218066_bib5","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.canlet.2025.218066_bib6","first-page":"346","article-title":"Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma","volume":"73","author":"Ruff","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.canlet.2025.218066_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.dld.2023.08.052","article-title":"Intrahepatic cholangiocarcinoma: evolving strategies in management and treatment","volume":"56","author":"Bragazzi","year":"2024","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"10.1016\/j.canlet.2025.218066_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000531458","article-title":"Recent advances in systemic therapy for advanced intrahepatic cholangiocarcinoma","volume":"13","author":"Yoo","year":"2024","journal-title":"Liver Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2025.218066_bib9","first-page":"211","article-title":"Particle therapy for intrahepatic cholangiocarcinoma: a multicenter prospective registry study, systematic review and meta-analysis","volume":"14","author":"Mizumoto","year":"2025","journal-title":"Liver Cancer"},{"key":"10.1016\/j.canlet.2025.218066_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(25)01042-6","article-title":"The lancet commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment","author":"Chan","year":"2025","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.canlet.2025.218066_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajpath.2024.10.021","article-title":"Development of CAR-T therapies and personalized vaccines for the treatment of cholangiocarcinoma: current progress, mechanisms of action, and challenges","volume":"195","author":"Li","year":"2025","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.canlet.2025.218066_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","article-title":"Histone recognition and large-scale structural analysis of the human bromodomain family","volume":"149","author":"Filippakopoulos","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.canlet.2025.218066_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2217\/epi.14.91","article-title":"Targeting BET bromodomains for cancer treatment","volume":"7","author":"Jung","year":"2015","journal-title":"Epigenomics"},{"issue":"10","key":"10.1016\/j.canlet.2025.218066_bib14","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1021\/acs.jmedchem.4c00210","article-title":"Impact of combinatorial histone modifications on acetyllysine recognition by the ATAD2 and ATAD2B bromodomains","volume":"67","author":"Phillips","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2025.218066_bib15","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s41467-019-09891-7","article-title":"BRD9 defines a SWI\/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.canlet.2025.218066_bib16","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1038\/s41388-021-01781-x","article-title":"Exploiting vulnerabilities of SWI\/SNF chromatin remodelling complexes for cancer therapy","volume":"40","author":"Wanior","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.218066_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123428","article-title":"Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): its therapeutic potential and selective inhibition","volume":"230","author":"Ali","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"7417","key":"10.1016\/j.canlet.2025.218066_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.218066_bib19","doi-asserted-by":"crossref","first-page":"13191","DOI":"10.2147\/OTT.S286867","article-title":"Targeting BRD9 for cancer treatment: a new strategy","volume":"13","author":"Zhu","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"9","key":"10.1016\/j.canlet.2025.218066_bib20","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1158\/1078-0432.CCR-22-3668","article-title":"BRD9 degradation disrupts ribosome biogenesis in multiple myeloma","volume":"29","author":"Kurata","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.canlet.2025.218066_bib21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41418-024-01306-5","article-title":"BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation","volume":"31","author":"Garg","year":"2024","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.canlet.2025.218066_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nchembio.2115","article-title":"Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition","volume":"12","author":"Hohmann","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.canlet.2025.218066_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41419-019-1570-9","article-title":"BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition","volume":"10","author":"Del Gaudio","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.canlet.2025.218066_bib24","first-page":"104","article-title":"The role of Stat5 transcription factors as tumor suppressors or oncogenes","volume":"1815","author":"Ferbeyre","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2025.218066_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2019.01.007","article-title":"miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9","volume":"446","author":"Huang","year":"2019","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.canlet.2025.218066_bib26","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2025.218066_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"17","key":"10.1016\/j.canlet.2025.218066_bib28","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1158\/0008-5472.CAN-11-0466","article-title":"Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin shedding","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2025.218066_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/19420862.2017.1289302","article-title":"Humanization of rabbit monoclonal antibodies via grafting combined Kabat\/IMGT\/Paratome complementarity-determining regions: rationale and examples","volume":"9","author":"Zhang","year":"2017","journal-title":"mAbs"},{"issue":"1","key":"10.1016\/j.canlet.2025.218066_bib30","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1038\/s41467-023-44081-6","article-title":"BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.canlet.2025.218066_bib31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41419-020-02943-7","article-title":"Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1\/AKT pathway","volume":"11","author":"Dou","year":"2020","journal-title":"Cell Death Dis."},{"issue":"11\u201312","key":"10.1016\/j.canlet.2025.218066_bib32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41434-024-00488-4","article-title":"BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K\/AKT pathway and represents a therapeutic target","volume":"31","author":"Qiang","year":"2024","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.canlet.2025.218066_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2006.10.017","article-title":"STAT3 as a central mediator of neoplastic cellular transformation","volume":"251","author":"Frank","year":"2007","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.canlet.2025.218066_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12094-012-0789-z","article-title":"Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis","volume":"14","author":"Sonnenblick","year":"2012","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.218066_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","article-title":"Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery","volume":"43","author":"Hu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.canlet.2025.218066_bib36","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.tips.2024.07.003","article-title":"Targeting the STAT3 pathway with STAT3 degraders","volume":"45","author":"Wang","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.canlet.2025.218066_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.218066_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-nutr-071812-161220","article-title":"Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism","volume":"34","author":"Pepino","year":"2014","journal-title":"Annu. Rev. Nutr."},{"issue":"7885","key":"10.1016\/j.canlet.2025.218066_bib39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41586-021-04075-0","article-title":"Dietary palmitic acid promotes a prometastatic memory via Schwann cells","volume":"599","author":"Pascual","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.canlet.2025.218066_bib40","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.canlet.2025.218066_bib41","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1038\/s41467-023-39752-3","article-title":"Endothelial cell CD36 regulates membrane ceramide formation, exosome fatty acid transfer and circulating fatty acid levels","volume":"14","author":"Peche","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.218066_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101592","article-title":"A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML","author":"Guo","year":"2024","journal-title":"Cell Rep. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352500638X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352500638X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:18:34Z","timestamp":1785273514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352500638X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":42,"alternative-id":["S030438352500638X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218066","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT3 induced BRD9 activation promotes intrahepatic cholangiocarcinoma progression by enhancing CD36 controlled fatty acid metabolism","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218066"}}